Post Covid Clinical Trial

Largest Long Covid cohort study published:

6 months post-hospital, 1400 people:

- 76% still had > 1 symptom

-63% fatigue/muscle weakness

- Anxiety, depression common


There are a large number of people who, despite having relatively mild COVID-19 symptoms, do not recover within a couple of weeks.

Lots of people have turned to online support groups and discuss having symptoms for months, and even calling themselves long-haulers. A report from a patient-led investigation in early May 2020 including 640 respondents showed that 90.6% of them had symptoms that lasted over 2 weeks with an average length of 27 days of symptoms.


Next to the common COVID-19 symptoms, reported additional symptoms included fatigue of varying severity, brain fog and concentration problems, insomnia, chills/sweats, and loss of appetite. 

Tune in to the below presentation from our Chief Medical Officer and Co-Founder, Dr. Sajad Zalzala, to learn more about Low Dose Naltrexone (LDN) and NAD+ for treatment of patients with post-COVID-19 syndrome. 

How This Trial Works

  • AgelessRx will enroll over 60 people for a 12 week study

  • Participants will be assigned to a treatment group or a control group

  • Participant in the treatment group will receive LDN and NAD+ treatment

  • Ongoing doctor evaluation will be provided to each participant

  • Surveys at 2, 4, 8, 12 weeks will be conducted to asses fatigue and quality of life

  • NAD+ supplementation using intophoresis patches (valued at $360). Learn More

  • LDN capsules for 12 weeks (valued at $105). Learn More

What participants will receive

Sign Up for More Information

If you're interested in learning more about the Post-COVID-19 trial, sign up using the form below.